Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful bone marrow transplantation in chronic granulomatous disease.
Miki M, Ono A, Awaya A, Miyagawa S, Onodera R, Kurita E, Hiraoka A, Hidaka F, Mizukami T, Nunoi H, Kobayashi M. Miki M, et al. Among authors: hiraoka a. Pediatr Int. 2009 Dec;51(6):838-41. doi: 10.1111/j.1442-200X.2009.02931.x. Pediatr Int. 2009. PMID: 20158628 No abstract available.
Monitoring neutrophil engraftment in allogeneic stem cell transplantation by flow cytometric analysis of neutrophil-specific antigens NA1 and NA2.
Inukai T, Uno K, Taniguchi K, Goi K, Tezuka T, Nemoto A, Takahashi K, Sato H, Akahane K, Hirose K, Honna H, Kagami K, Hiraoka A, Tanihiro M, Nakazawa S, Sugita K. Inukai T, et al. Among authors: hiraoka a. Br J Haematol. 2007 Oct;139(2):280-3. doi: 10.1111/j.1365-2141.2007.06778.x. Epub 2007 Aug 30. Br J Haematol. 2007. PMID: 17764467 Free article.
Publisher Correction: Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy.
Watanabe T, Tokumoto Y, Ochi H, Mashiba T, Tada F, Hiraoka A, Kisaka Y, Tanaka Y, Yagi S, Nakanishi S, Sunago K, Yamauchi K, Higashino M, Hirooka K, Tange M, Yukimoto A, Morita M, Okazaki Y, Hirooka M, Abe M, Hiasa Y. Watanabe T, et al. Among authors: hiraoka a. J Gastroenterol. 2025 Jan 12. doi: 10.1007/s00535-024-02196-7. Online ahead of print. J Gastroenterol. 2025. PMID: 39799525 No abstract available.
Reliable Performance of mALBI Grade-Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First-Line Treatment: Comparative Analysis of 13 Risk Models.
Hatanaka T, Kakizaki S, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Toyoda H, Ogawa C, Nishikawa H, Nishimura T, Kawata K, Kosaka H, Naganuma A, Yata Y, Ohama H, Kuroda H, Matono T, Tanaka K, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Kumada T; Real‐life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hatanaka T, et al. Among authors: hiraoka a. J Gastroenterol Hepatol. 2025 Jan 6. doi: 10.1111/jgh.16871. Online ahead of print. J Gastroenterol Hepatol. 2025. PMID: 39762722
608 results